https://ir.neogenomics.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_9ddaa063008c3c93d1b4ef2454e485d2/neogenomics/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.neogenomics.com/news-events/press-releases/detail/327/neogenomics-reports-first-quarter-2026-results Tue, 28 Apr 26 16:05:00 -0400 https://ir.neogenomics.com/news-events/press-releases/detail/327/neogenomics-reports-first-quarter-2026-results https://ir.neogenomics.com/news-events/press-releases/detail/326/neogenomics-expands-access-to-full-oncology-testing-portfolio-through-epic-aura-integration Thu, 23 Apr 26 07:05:00 -0400 https://ir.neogenomics.com/news-events/press-releases/detail/326/neogenomics-expands-access-to-full-oncology-testing-portfolio-through-epic-aura-integration https://ir.neogenomics.com/news-events/press-releases/detail/325/neogenomics-to-present-multiple-abstracts-showcasing-new-research-at-aacr-annual-meeting-2026 Mon, 13 Apr 26 07:05:00 -0400 https://ir.neogenomics.com/news-events/press-releases/detail/325/neogenomics-to-present-multiple-abstracts-showcasing-new-research-at-aacr-annual-meeting-2026 https://ir.neogenomics.com/news-events/press-releases/detail/324/neogenomics-to-report-first-quarter-2026-financial-results-on-april-28-2026 Tue, 07 Apr 26 07:05:00 -0400 https://ir.neogenomics.com/news-events/press-releases/detail/324/neogenomics-to-report-first-quarter-2026-financial-results-on-april-28-2026 https://ir.neogenomics.com/news-events/press-releases/detail/323/neogenomics-pantracer-lbx-receives-medicare-coverage-expanding-access-to-comprehensive-liquid-biopsy-profiling Mon, 16 Mar 26 07:05:00 -0400 https://ir.neogenomics.com/news-events/press-releases/detail/323/neogenomics-pantracer-lbx-receives-medicare-coverage-expanding-access-to-comprehensive-liquid-biopsy-profiling https://ir.neogenomics.com/news-events/press-releases/detail/322/neogenomics-launches-radar-st-expanding-molecular-residual-disease-testing-across-multiple-solid-tumor-types Wed, 25 Feb 26 07:05:00 -0500 https://ir.neogenomics.com/news-events/press-releases/detail/322/neogenomics-launches-radar-st-expanding-molecular-residual-disease-testing-across-multiple-solid-tumor-types https://ir.neogenomics.com/news-events/press-releases/detail/321/neogenomics-to-participate-in-upcoming-investor-conferences Wed, 18 Feb 26 07:05:00 -0500 https://ir.neogenomics.com/news-events/press-releases/detail/321/neogenomics-to-participate-in-upcoming-investor-conferences https://ir.neogenomics.com/news-events/press-releases/detail/320/neogenomics-reports-fourth-quarter-and-full-year-2025-results Tue, 17 Feb 26 07:05:00 -0500 https://ir.neogenomics.com/news-events/press-releases/detail/320/neogenomics-reports-fourth-quarter-and-full-year-2025-results https://ir.neogenomics.com/news-events/press-releases/detail/319/neogenomics-introduces-pantracer-pro-to-support-timely-informed-solid-tumor-therapy-selection Thu, 12 Feb 26 07:05:00 -0500 https://ir.neogenomics.com/news-events/press-releases/detail/319/neogenomics-introduces-pantracer-pro-to-support-timely-informed-solid-tumor-therapy-selection https://ir.neogenomics.com/news-events/press-releases/detail/318/neogenomics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-17-2026 Tue, 27 Jan 26 07:05:00 -0500 https://ir.neogenomics.com/news-events/press-releases/detail/318/neogenomics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-17-2026